-
Four New Participants Enroll in Smoked Marijuana Trial for Chronic PTSD in Veterans
-
7 New Participants Enroll in Smoked Marijuana Trial for Chronic PTSD in Veterans
-
4th, 5th, and 6th Participants Enrolled in Smoked Marijuana Trial for Chronic PTSD in Veterans
-
Second and Third Participants Self-Administered Treatment in Trial of Marijuana for Chronic PTSD in Veterans
-
Marijuana for PTSD: First Participant Enrolled in First-Ever Trial of Marijuana for Chronic PTSD in Veterans
-
Marijuana for PTSD: In-Person Participant Screening Begins in Arizona
-
Marijuana for PTSD: Participant Screening Begins in Phoenix, Arizona
-
Marijuana for PTSD: Marijuana Received from NIDA at Phoenix Site
-
Marijuana for PTSD: NIDA Approves Order of 6.3kg of Marijuana
-
Marijuana for PTSD: Investigator Meetings and Initiation Visits Begin
-
Marijuana for PTSD: DEA Approves First-Ever Trial of Medical Marijuana for PTSD in Veterans
-
Marijuana for PTSD: Phoenix Site Seeks Study Coordinator
-
Marijuana for PTSD: Dr. Sue Sisley Speaks to American Legion about Barriers to Research
-
Marijuana for PTSD: DEA Inspects Johns Hopkins Trial Site
-
Medical Marijuana for PTSD: Protocol Submitted to DEA
-
Medical Marijuana for PTSD: Johns Hopkins IRB Approves Protocol Design
-
NIDA Provides Marijuana Cost and Availability Information
-
Public Health Service Approves Amended Protocol
-
Revised Grant Application Approved; Sue Sisley to Receive Researcher of the Year Award
-
MAPS Receives $2 Million Grant from Colorado for Study of Medical Marijuana for PTSD